STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME)

An extension of the STROBE statement

Valentina Gallo, Matthias Egger, Valerie McCormack, Peter B. Farmer, John P A Ioannidis, Micheline Kirsch-Volders, Giuseppe Matullo, David H. Phillips, B. Schoket, Ulf Stromberg, Roel Vermeulen, Christopher Wild, Miquel Porta, Paolo Vineis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and / or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

Original languageEnglish
Pages (from-to)17-29
Number of pages13
JournalMutagenesis
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Epidemiology
Molecular Epidemiology
Observational Studies
Biomarkers
Epidemiologic Studies
Checklist
Proxy
Research
Reproducibility of Results
Case-Control Studies
Cohort Studies
Cross-Sectional Studies
Guidelines

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Gallo, V., Egger, M., McCormack, V., Farmer, P. B., Ioannidis, J. P. A., Kirsch-Volders, M., ... Vineis, P. (2012). STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement. Mutagenesis, 27(1), 17-29. https://doi.org/10.1093/mutage/ger039

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement. / Gallo, Valentina; Egger, Matthias; McCormack, Valerie; Farmer, Peter B.; Ioannidis, John P A; Kirsch-Volders, Micheline; Matullo, Giuseppe; Phillips, David H.; Schoket, B.; Stromberg, Ulf; Vermeulen, Roel; Wild, Christopher; Porta, Miquel; Vineis, Paolo.

In: Mutagenesis, Vol. 27, No. 1, 01.2012, p. 17-29.

Research output: Contribution to journalArticle

Gallo, V, Egger, M, McCormack, V, Farmer, PB, Ioannidis, JPA, Kirsch-Volders, M, Matullo, G, Phillips, DH, Schoket, B, Stromberg, U, Vermeulen, R, Wild, C, Porta, M & Vineis, P 2012, 'STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement', Mutagenesis, vol. 27, no. 1, pp. 17-29. https://doi.org/10.1093/mutage/ger039
Gallo, Valentina ; Egger, Matthias ; McCormack, Valerie ; Farmer, Peter B. ; Ioannidis, John P A ; Kirsch-Volders, Micheline ; Matullo, Giuseppe ; Phillips, David H. ; Schoket, B. ; Stromberg, Ulf ; Vermeulen, Roel ; Wild, Christopher ; Porta, Miquel ; Vineis, Paolo. / STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement. In: Mutagenesis. 2012 ; Vol. 27, No. 1. pp. 17-29.
@article{68776319ec644caeacbd3d43821f869a,
title = "STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement",
abstract = "Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and / or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.",
author = "Valentina Gallo and Matthias Egger and Valerie McCormack and Farmer, {Peter B.} and Ioannidis, {John P A} and Micheline Kirsch-Volders and Giuseppe Matullo and Phillips, {David H.} and B. Schoket and Ulf Stromberg and Roel Vermeulen and Christopher Wild and Miquel Porta and Paolo Vineis",
year = "2012",
month = "1",
doi = "10.1093/mutage/ger039",
language = "English",
volume = "27",
pages = "17--29",
journal = "Mutagenesis",
issn = "0267-8357",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME)

T2 - An extension of the STROBE statement

AU - Gallo, Valentina

AU - Egger, Matthias

AU - McCormack, Valerie

AU - Farmer, Peter B.

AU - Ioannidis, John P A

AU - Kirsch-Volders, Micheline

AU - Matullo, Giuseppe

AU - Phillips, David H.

AU - Schoket, B.

AU - Stromberg, Ulf

AU - Vermeulen, Roel

AU - Wild, Christopher

AU - Porta, Miquel

AU - Vineis, Paolo

PY - 2012/1

Y1 - 2012/1

N2 - Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and / or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

AB - Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and / or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

UR - http://www.scopus.com/inward/record.url?scp=84555177878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555177878&partnerID=8YFLogxK

U2 - 10.1093/mutage/ger039

DO - 10.1093/mutage/ger039

M3 - Article

VL - 27

SP - 17

EP - 29

JO - Mutagenesis

JF - Mutagenesis

SN - 0267-8357

IS - 1

ER -